Aug 31, 2022
The US Now Has a Research Plan for Long COVID—Is It Enough?;
Debate Swirls Around the Relevance of the Amyloid Hypothesis in
Alzheimer Disease Research; Microplastics Are Found Outside in
Nature and Inside the Body—but Evidence of Health Risks Is
Inconclusive
Related Content:
- The US Now Has a Research Plan for Long COVID—Is It Enough?
- Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches
- Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive
- Animal Reservoirs—Where the Next SARS-CoV-2 Variant Could Arise
- Large Autopsy Study Estimates Prevalence of “LATE” Neuropathologic Change
- Addressing the Long-term Effects of COVID-19
- Long COVID: The US Federal Response (audio)
- Long COVID: The US Federal Response (video)